{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:04:27Z","timestamp":1780448667506,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02269-w","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:45:30Z","timestamp":1776260730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TFRC promotes ferroptosis to suppress breast cancer bone metastasis via the activation of HIF-1 pathway"],"prefix":"10.1186","volume":"28","author":[{"given":"Lulin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangtian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2269_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2269_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Ding ZLW, Chen Y, Cai YF, Wang YW, Huang LP, Liu L, Shao CC, Yu ZM. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2269_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346.","journal-title":"Int J Cancer"},{"issue":"1","key":"2269_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13578-023-01171-8","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Wu W, Lin X, Zhang KM, Wu Q, Luo M, Zhou J. Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. Cell Biosci. 2023;13(1):224.","journal-title":"Cell Biosci"},{"issue":"2","key":"2269_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41416-021-01564-x","volume":"126","author":"SK Herzog","year":"2022","unstructured":"Herzog SK, Fuqua SAW. ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. Br J Cancer. 2022;126(2):174\u201386.","journal-title":"Br J Cancer"},{"issue":"2","key":"2269_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2269_CR7","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Jia YC, Ding YX, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19(9):2756\u201371.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2269_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/1061186X.2024.2399181","volume":"33","author":"S Zhang","year":"2025","unstructured":"Zhang S, Guo L, Tao R, Liu S. Ferroptosis-targeting drugs in breast cancer. J Drug Target. 2025;33(1):42\u201359.","journal-title":"J Drug Target"},{"issue":"8","key":"2269_CR9","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.7150\/ijbs.82120","volume":"19","author":"YM Chen","year":"2023","unstructured":"Chen YM, Xu W, Liu Y, Zhang JH, Yang YY, Wang ZW, Sun DJ, Li H, Liu B, Chen LX. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer. Int J Biol Sci. 2023;19(8):2531\u201350.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"2269_CR10","doi-asserted-by":"publisher","first-page":"e18212","DOI":"10.1111\/jcmm.18212","volume":"28","author":"G He","year":"2024","unstructured":"He G, Zhang Y, Feng Y, Chen T, Liu M, Zeng Y, Yin X, Qu S, Huang L, Ke Y, Liang L, Yan J, Liu W. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation. J Cell Mol Med. 2024;28(7):e18212.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"2269_CR11","doi-asserted-by":"publisher","first-page":"e2207693","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, Liu VLB, Haneef Z, Falcon M, Martin DM, Lee DR, Dame HJ, Attili MK, Chen D, Varani Y, Spence J, Kovbasnjuk JR, Colacino O, Lyssiotis JA, Lin CA, Shah HC, Xue YM. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. Adv Sci (Weinh). 2023;10(10):e2207693.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"2269_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41419-024-07013-w","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Nie M, Xin X, Hua T, Zhang J, Shi R, Dong K, Shu W, Yan B, Wang H. RAB17 promotes endometrial cancer progression by inhibiting TFRC-dependent ferroptosis. Cell Death Dis. 2024;15(9):655.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2269_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2016.02.023","volume":"471","author":"SM Jeong","year":"2016","unstructured":"Jeong SM, Hwang S, Seong RH. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation. Biochem Biophys Res Commun. 2016;471(3):373\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2269_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.blre.2018.04.004","volume":"32","author":"A Isidori","year":"2018","unstructured":"Isidori A, Borin L, Elli E, Latagliata R, Martino B, Palumbo G, Pilo F, Loscocco F, Visani G, Cianciulli P. Iron toxicity - Its effect on the bone marrow. Blood Rev. 2018;32(6):473\u20139.","journal-title":"Blood Rev"},{"key":"2269_CR15","doi-asserted-by":"crossref","unstructured":"Li T, Du Y, Yao H, Zhao B, Wang Z, Chen R, Ji Y, Du M. Isobavachin attenuates osteoclastogenesis and periodontitis-induced bone loss by inhibiting cellular iron accumulation and mitochondrial biogenesis. Biochem Pharmacol, 2024, 224116202.","DOI":"10.1016\/j.bcp.2024.116202"},{"issue":"5","key":"2269_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10585-016-9792-z","volume":"33","author":"W Wang","year":"2016","unstructured":"Wang W, Belosay A, Yang X, Hartman JA, Song H, Iwaniec UT, Turner RT, Churchwell MI, Doerge DR, Helferich WG. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells. Clin Exp Metastasis. 2016;33(5):475\u201385.","journal-title":"Clin Exp Metastasis"},{"issue":"D1","key":"2269_CR17","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):D672\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2269_CR18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.bmc.2016.06.021","volume":"25","author":"J Wei","year":"2017","unstructured":"Wei J, Yang Y, Li Y, Mo X, Guo X, Zhang X, Xu X, Jiang Z, You Q. Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. Bioorg Med Chem. 2017;25(6):1737\u201346.","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"2269_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11914-021-00677-9","volume":"19","author":"M Puppo","year":"2021","unstructured":"Puppo M, Valluru MK, Cl\u00e9zardin P. MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Curr Osteoporos Rep. 2021;19(3):256\u201363.","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"2269_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2269_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, Qin L, Hu L, Zhou J. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83\u201398.","journal-title":"Oncogene"},{"issue":"10","key":"2269_CR22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","volume":"35","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan D, Chang W, Peng X, Sung ES, Gilbert K, Zhu Y, Wang X, Zeng Z, Baldwin H, Ren G, Weaver J, Huron A, Mayberry T, Wang Q, Wang Y, Diaz-Rubio ME, Su X, Stack MS, Zhang S, Lu X, Sheldon RD, Li J, Zhang C, Wan J, Lu X. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metab. 2023;35(10):1688\u2013e17031610.","journal-title":"Cell Metab"},{"issue":"1","key":"2269_CR23","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, Mcdonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12(1):5103.","journal-title":"Nat Commun"},{"key":"2269_CR24","doi-asserted-by":"crossref","unstructured":"Candelaria PV, Leoh LS, Penichet ML, Daniels-Wells TR. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents. Front Immunol, 2021, 12607692.","DOI":"10.3389\/fimmu.2021.607692"},{"issue":"Pt 1","key":"2269_CR25","doi-asserted-by":"publisher","first-page":"133323","DOI":"10.1016\/j.ijbiomac.2024.133323","volume":"274","author":"J Qin","year":"2024","unstructured":"Qin J, Li Z, Su L, Wen X, Tang X, Huang M, Wu J. Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer. Int J Biol Macromol. 2024;274(Pt 1):133323.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2269_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13062-023-00373-x","volume":"18","author":"TY Liu","year":"2023","unstructured":"Liu TY, Hu CC, Han CY, Mao SY, Zhang WX, Xu YM, Sun YJ, Jiang DB, Zhang XY, Zhang JX, Wang J, Qiao XP, Pan JY, Yang SY, Yang K. IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism. Biol Direct. 2023;18(1):19.","journal-title":"Biol Direct"},{"issue":"1","key":"2269_CR27","doi-asserted-by":"publisher","first-page":"20230882","DOI":"10.1515\/med-2023-0882","volume":"19","author":"P Zhang","year":"2024","unstructured":"Zhang P, Wang S, Chen Y, Yang Q, Zhou J, Zang W. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC. Open Med (Wars). 2024;19(1):20230882.","journal-title":"Open Med (Wars)"},{"issue":"5","key":"2269_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/cas.70015","volume":"116","author":"Y Yang","year":"2025","unstructured":"Yang Y, Ning Y, Chen Y, Tian T, Gao X, Kong Y, Lei K, Cui Z. Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K\/AKT\/mTOR Signaling Pathway. Cancer Sci. 2025;116(5):1352\u201365.","journal-title":"Cancer Sci"},{"issue":"2","key":"2269_CR29","first-page":"826","volume":"42","author":"H Yu","year":"2019","unstructured":"Yu H, Yang C, Jian L, Guo S, Chen R, Li K, Qu F, Tao K, Fu Y, Luo F, Liu S. Sulfasalazine\u2013induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncol Rep. 2019;42(2):826\u201338.","journal-title":"Oncol Rep"},{"key":"2269_CR30","doi-asserted-by":"publisher","first-page":"145796","DOI":"10.1016\/j.gene.2021.145796","volume":"798","author":"M Rashid","year":"2021","unstructured":"Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, Ramezani F. Up-down regulation of HIF-1\u03b1 in cancer progression. Gene. 2021;798:145796.","journal-title":"Gene"},{"issue":"10","key":"2269_CR31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/procel\/pwae010","volume":"15","author":"D Feng","year":"2024","unstructured":"Feng D, Gao J, Liu R, Liu W, Gao T, Yang Y, Zhang D, Yang T, Yin X, Yu H, Huang W, Wang Y. CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A. Protein Cell. 2024;15(10):744\u201365.","journal-title":"Protein Cell"},{"key":"2269_CR32","doi-asserted-by":"publisher","first-page":"113922","DOI":"10.1016\/j.bcp.2020.113922","volume":"175","author":"N Kachamakova-Trojanowska","year":"2020","unstructured":"Kachamakova-Trojanowska N, Podkalicka P, Bogacz T, Barwacz S, J\u00f3zkowicz A, Dulak J, \u0141oboda A. HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. Biochem Pharmacol. 2020;175:113922.","journal-title":"Biochem Pharmacol"},{"issue":"11\u201312","key":"2269_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41417-019-0078-x","volume":"26","author":"X Xu","year":"2019","unstructured":"Xu X, Liu T, Wu J, Wang Y, Hong Y, Zhou H. Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer. Cancer Gene Ther. 2019;26(11\u201312):356\u201365.","journal-title":"Cancer Gene Ther"},{"issue":"15","key":"2269_CR34","doi-asserted-by":"publisher","first-page":"e23876","DOI":"10.1096\/fj.202401119R","volume":"38","author":"X Yu","year":"2024","unstructured":"Yu X, Guo Q, Zhang H, Wang X, Han Y, Yang Z. Hypoxia-inducible factor-1\u03b1 can reverse the Adriamycin resistance of breast cancer adjuvant chemotherapy by upregulating transferrin receptor and activating ferroptosis. Faseb j. 2024;38(15):e23876.","journal-title":"Faseb j"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02269-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02269-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:03:00Z","timestamp":1780444980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02269-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2269"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02269-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments conformed to the Guide for the Care and Use of Laboratory Animals. Animal study has been approved by the Animal Ethics Committee of Kunshan First People\u2019s Hospital. All methods are reported in accordance with ARRIVE guidelines. Ethical endorsement for human study was secured from the Ethics Committee of Kunshan First People\u2019s Hospital, ensuring full adherence to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}